The Frontier of Animal Disease Prevention and Treatment

Veterinary biologics are a class of biological products used to prevent, treat, or diagnose animal diseases.

By Product Type:

• Vaccines: This segment holds the largest market share and is the primary driver of the market. Vaccines are cost-effective and widely used to prevent a multitude of infectious diseases in both companion and production animals. This includes live attenuated, inactivated, subunit, toxoid, and increasingly, DNA/RNA vaccines.
• Bacterins: Vaccines specifically targeting bacterial infections.
• Antisera/Antibodies: Used for passive immunity or immediate protection against specific diseases. Monoclonal antibodies (mAbs) are an emerging sub-segment with high growth potential for targeted therapies.
• Diagnostic Kits: Biologic-based kits used for disease detection and diagnosis in animals.
• Others: Including immunomodulators and other biologic therapeutic agents.

By Animal Type:

• Livestock Animals: This segment, particularly within the vaccines category, is expected to dominate the market. The high demand for meat, dairy, and poultry products globally necessitates rigorous disease prevention and control in large animal populations. This includes cattle, poultry, swine, and aquaculture.
• Companion Animals: This segment, including dogs, cats, and horses (equine), is growing rapidly.

Market Drivers and Future Outlook

The global Veterinary Biologics Market is estimated at USD 16.08 billion in 2025 and is expected to reach USD 21.71 billion by 2030, at a CAGR of 6.20%. Another report projects the market to exceed USD 25 billion by 2033, with a CAGR of 7% from 2025 to 2033. Key drivers include:

• Increasing Pet Ownership and Humanization of Pets: The growing trend of pets as family members leads to higher expenditure on preventive healthcare and advanced treatments.
• Rising Global Demand for Animal Protein: The burgeoning human population's demand for meat, milk, and eggs necessitates healthy and productive livestock, driving the use of biologics for disease prevention and performance enhancement.
• Increasing Prevalence of Infectious Diseases in Animals: Outbreaks of diseases like avian influenza, African swine fever, and rabies underscore the critical need for effective vaccines and other biologics to control and prevent widespread infections.
• Advancements in Biotechnology and Genomics: Breakthroughs in recombinant DNA technology, genetic engineering, and a deeper understanding of animal immunology are leading to the development of more effective, safer, and targeted biologics. Asia Pacific is poised for significant growth, driven by large livestock populations and increasing pet ownership.Challenges include stringent regulatory approval processes, the high cost of RD for novel biologics, and public concerns regarding the use of biologics in food-producing animals.
• Growth in Monoclonal Antibody (mAb) Therapies: For targeted treatment of various animal diseases, including cancer and autoimmune conditions.
• Focus on Oral and Needle-Free Delivery Systems: For easier administration and reduced stress in animals.
• Integration of Diagnostics with Biologics: Companion diagnostics to identify animals that would best respond to specific biologic therapies.
• Emphasis on Sustainable and Ethical Production: Adherence to high animal welfare standards in biologic development.

The veterinary biologics market is a dynamic and essential sector, constantly evolving to meet the complex challenges of animal health, food security, and public health, offering innovative solutions for disease prevention and treatment in a rapidly changing world.

Explore our latest reports

? Stay ahead in the healthcare industry. Browse our latest insights now!

About Market Research Future (MRFR)
Market Research Future (MRFR) is a global market research firm that provides comprehensive insights into market trends, drivers, challenges, and opportunities. We offer a broad range of market intelligence reports and consulting services to help businesses and enterprises in various industries make informed decisions

Media Contact:
Market Research Future (MRFR)
Phone: +1-646-845-9312
Email: contact@marketresearchfuture.com
Website: marketresearchfuture